Aptamers to von Willebrand factor and their use as thrombotic disease therapeutics

The invention relates generally to the field of nucleic acids and more particularly to aptamers capable of binding to von Willebrand Factor useful as therapeutics in and diagnostics of thrombotic diseases and/or other diseases or disorders in which von Willebrand Factor mediated platelet aggregation...

Full description

Saved in:
Bibliographic Details
Main Authors LAGASSE H. A. DANIEL, BENEDICT CLAUDE, DIENER JOHN L
Format Patent
LanguageEnglish
Published 16.08.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates generally to the field of nucleic acids and more particularly to aptamers capable of binding to von Willebrand Factor useful as therapeutics in and diagnostics of thrombotic diseases and/or other diseases or disorders in which von Willebrand Factor mediated platelet aggregation has been implicated. The invention further relates to materials and methods for the administration of aptamers capable of binding to von Willebrand Factor.
Bibliography:Application Number: US20090322078